What type of study is this?

This is a In Vitro Study study.

November 28, 2025BMC ImmunologyOpen Access

FTO-mediated m6A demethylation of BECN1 mRNA promotes hepatic steatosis by impairing autophagy

View Full Paper

Ask AI

Bookmark

Authors

LLLijuan Liu BJBin Ji

Discussion

Member takes

Implication

In vitro and in vivo findings reveal FTO's role in impaired autophagy and lipid accumulation in hepatic steatosis, suggesting a therapeutic target for metabolic disorders.

Key Points

Hepatic steatosis was improved with FTO knockdown, reducing lipid accumulation and enhancing autophagy.
In HepG2 cells, FTO demethylation resulted in notable changes in lipid metabolism and autophagy markers.
Assessed using in vitro and in vivo models, including fatty acids, dot blot, and Western blot analysis.
Findings highlight FTO's potential as a treatment target for hyperlipidemia and metabolic disorders.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/6928f113a65b730b9ea79e4d https://doi.org/10.1186/s12865-025-00784-7

View Full Paper

Ask AI

Bookmark

Implication

In vitro and in vivo findings reveal FTO's role in impaired autophagy and lipid accumulation in hepatic steatosis, suggesting a therapeutic target for metabolic disorders.

FTO-mediated m6A demethylation of BECN1 mRNA promotes hepatic steatosis by impairing autophagy

Discussion

Member takes

Implication

Key Points

Cite This Study

FTO-mediated m6A demethylation of BECN1 mRNA promotes hepatic steatosis by impairing autophagy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider